PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Armitage, Jane
TI  - HPS2-THRIVE: Niacin Fails to Show Benefit in Patients at High Risk of Vascular Events
DP  - 2013 May 01
TA  - MD Conference Express
PG  - 13--14
VI  - 13
IP  - 2
4099  - http://mdc.sagepub.com/content/13/2/13.short
4100  - http://mdc.sagepub.com/content/13/2/13.full
AB  - The results of this large randomized controlled trial in patients with well-controlled lipid levels but who are at a high risk of cardiovascular events once again call into question the the clinical benefits of niacin despite an increase in high-density lipoprotein cholesterol (HDL-C), and reductions in triglyceride levels and low density lipoprotein cholesterol levels. This article presents the results of the Treatment of HDL to Reduce the Incidence of Vascular Events trial [HPS2-THRIVE Collaborative Group. Eur Heart J 2013].